Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R7FS
|
||||
| Former ID |
DIB016200
|
||||
| Drug Name |
BPI-704001
|
||||
| Synonyms |
BPI-704001; BPI-705001; BPI-715001; PARP-1 inhibitors (cancer); PARP-1 inhibitors (cancer), Beta Pharma
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543709] | ||
| Company |
Beta Pharma Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Inhibitor | [543709] | |
| KEGG Pathway | Base excision repair | ||||
| NF-kappa B signaling pathway | |||||
| PANTHER Pathway | FAS signaling pathway | ||||
| Pathway Interaction Database | Integrin-linked kinase signaling | ||||
| Caspase Cascade in Apoptosis | |||||
| Notch-mediated HES/HEY network | |||||
| Reactome | Dual Incision in GG-NER | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.